Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas
This study has been completed.
Study NCT00490399   Information provided by Eli Lilly and Company

First Received on June 20, 2007.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Biliary Tract Carcinoma
Additional conditions recognized in this trial
Carcinoma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Glandular and Epithelial
Interventions listed in this trial
gemcitabine
cisplatin
More general drug interventions related to this trial
Anti-Infective Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antiviral Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services